Toho Holdings
8129.TWholesale Trade
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥1.55T | ¥1.52T | ¥1.48T | ¥1.39Tr | ¥1.27T | ¥1.21T |
| Operating income | ¥16.6bn | ¥18.9bn | ¥19.3bn | ¥16.4bnr | ¥12.5bn | ¥4.3bn |
| Ordinary income | ¥16.6bn | ¥20.7bn | ¥21.8bn | ¥19.2bn | ¥18.2bn | ¥10.3bn |
| Net income (owners) | ¥17.3bn | ¥19.8bn | ¥20.7bn | ¥13.6bn | ¥13.4bn | ¥5.0bn |
| Total assets | ¥740.8bn | ¥722.8bn | ¥773.4bn | ¥715.3bn | ¥702.4bn | ¥683.2bn |
| Net assets / equity | ¥271.6bn | ¥256.9bn | ¥249.4bn | ¥242.9bn | ¥241.3bn | ¥237.4bn |
| Operating cash flow | ¥19.2bn | −¥26.7bn | ¥59.9bn | −¥9m | ¥16.3bn | ¥8.8bn |
| EPS (basic) | ¥271.18 | ¥313.2 | ¥320.14 | ¥196.7 | ¥189.7 | ¥70.77 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 6
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 52 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 76 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 50 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 52 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 76 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 50 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Dispensing Pharmacy | ¥100.5bn | ¥1.4bn |
| Medical Products Manufacturing And Sales | ¥2.7bn | ¥282m |
| Medical Products Retail | ¥1.44T | ¥16.8bn |
| Adjustments & eliminations | — | −¥2.7bn |
| Total | ¥1.55T | ¥19.3bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.